The Edelman Financial Group
Stage
AcquiredInvestors Count
3Deal Terms
1Portfolio Exits
2Investments
7Funding, Valuation & Revenue
3 Fundings
The Edelman Financial Group's latest funding round was a Merger for on July 23, 2018.
The Edelman Financial Group's valuation in September 2012 was $258M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
7/23/2018 | Merger | 1 | ||||
10/13/2015 | Acq - Fin - II | |||||
9/14/2012 | Acq - Fin | $258M |
Date | 7/23/2018 | 10/13/2015 | 9/14/2012 |
---|---|---|---|
Round | Merger | Acq - Fin - II | Acq - Fin |
Amount | |||
Investors | |||
Valuation | $258M | ||
Revenue | |||
Sources | 1 |
The Edelman Financial Group Deal Terms
1 Deal Term
The Edelman Financial Group's deal structure is available for 1 funding round, including their Acq - Fin from September 14, 2012.
Round | Acq - Fin |
---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - Fin |
The Edelman Financial Group Investors
3 Investors
The Edelman Financial Group has 3 investors. Edelman Financial Engines invested in The Edelman Financial Group's Merger funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
7/23/2018 | 7/23/2018 | 1 Merger | Asset/Investment Management | California | ||
Private Equity | California | |||||
Private Equity | New York |
First funding | 7/23/2018 | ||
---|---|---|---|
Last Funding | 7/23/2018 | ||
Investor | |||
Rounds | 1 Merger | ||
Board Seats | |||
Type | Asset/Investment Management | Private Equity | Private Equity |
Location | California | California | New York |
The Edelman Financial Group Investments
7 Investments
The Edelman Financial Group has made 7 investments. Their latest investment was in Direvo Biotech as part of their Series B on November 26, 2002.
The Edelman Financial Group Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
11/26/2002 | Series B | Direvo Biotech | $10.51M | Yes | Danisco Venture, Mulligan BioCapital, TVM Capital Life Science, Undisclosed Angel Investors, and Undisclosed Investors | 1 |
5/29/2002 | Seed | |||||
3/14/1997 | Growth Equity - II | |||||
8/9/1996 | Growth Equity | |||||
4/1/1991 | Series C |
Date | 11/26/2002 | 5/29/2002 | 3/14/1997 | 8/9/1996 | 4/1/1991 |
---|---|---|---|---|---|
Round | Series B | Seed | Growth Equity - II | Growth Equity | Series C |
Company | Direvo Biotech | ||||
Amount | $10.51M | ||||
New? | Yes | ||||
Co-Investors | Danisco Venture, Mulligan BioCapital, TVM Capital Life Science, Undisclosed Angel Investors, and Undisclosed Investors | ||||
Sources | 1 |
The Edelman Financial Group Portfolio Exits
2 Portfolio Exits
The Edelman Financial Group has 2 portfolio exits. Their latest portfolio exit was Direvo Biotech on September 16, 2008.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
9/16/2008 | Acquired | ||||
Date | 9/16/2008 | |
---|---|---|
Exit | Acquired | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources |
Loading...